Exploiting interkingdom interactions for development of small-molecule inhibitors of Candida albicans biofilm formation
dc.contributor.author | Reen, F. Jerry | |
dc.contributor.author | Phelan, John P. | |
dc.contributor.author | Gallagher, Lorna | |
dc.contributor.author | Woods, David F. | |
dc.contributor.author | Shanahan, Rachel M. | |
dc.contributor.author | Cano, Rafael | |
dc.contributor.author | Ó Muimhneacháin, Eoin | |
dc.contributor.author | McGlacken, Gerard P. | |
dc.contributor.author | O'Gara, Fergal | |
dc.contributor.funder | Science Foundation Ireland | en |
dc.contributor.funder | Seventh Framework Programme | en |
dc.contributor.funder | Health Research Board | en |
dc.contributor.funder | Teagasc | en |
dc.contributor.funder | Department of Agriculture, Food and the Marine | en |
dc.contributor.funder | Food Institutional Research Measure | en |
dc.contributor.funder | Irish Research Council for Science, Engineering and Technology | en |
dc.contributor.funder | Marine Institute | en |
dc.contributor.funder | Irish Research Council | en |
dc.contributor.funder | University College Cork | en |
dc.date.accessioned | 2019-10-23T11:12:32Z | |
dc.date.available | 2019-10-23T11:12:32Z | |
dc.date.issued | 2016-07-25 | |
dc.date.updated | 2019-10-23T10:52:01Z | |
dc.description.abstract | A rapid decline in the development of new antimicrobial therapeutics has coincided with the emergence of new and more aggressive multidrug-resistant pathogens. Pathogens are protected from antibiotic activity by their ability to enter an aggregative biofilm state. Therefore, disrupting this process in pathogens is a key strategy for the development of next-generation antimicrobials. Here, we present a suite of compounds, based on the Pseudomonas aeruginosa 2-heptyl-4(1H)-quinolone (HHQ) core quinolone interkingdom signal structure, that exhibit noncytotoxic antibiofilm activity toward the fungal pathogen Candida albicans. In addition to providing new insights into what is a clinically important bacterium-fungus interaction, the capacity to modularize the functionality of the quinolone signals is an important advance in harnessing the therapeutic potential of signaling molecules in general. This provides a platform for the development of potent next-generation small-molecule therapeutics targeting clinically relevant fungal pathogens. | en |
dc.description.sponsorship | Health Research Board (HRB (Irish Thoracic Society MRCG-2014-6)); (Walsh Fellowship 2013); Teagasc (Walsh Fellowship 2013); Department of Agriculture, Food and the Marine (Food Institutional Research Measure (FIRM/RSF/CoFoRD, FIRM 08/RDC/629, FIRM 1/F009/MabS, and FIRM 13/F/516)); Irish Research Council for Science, Engineering and Technology ((IRCSET) (PD/2011/2414 and GOIPG/2014/647)); Marine Institute ((Foras Na Mara) (Beaufort award C2CRA 2007/082)); University College Cork (UCC Strategic Research Fund) | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Accepted Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.citation | Reen, F. J., Phelan, J. P., Gallagher, L., Woods, D. F., Shanahan, R. M., Cano, R., Ó Muimhneacháin, E., McGlacken, G. P. and O'Gara, F. (2016) ‘Exploiting interkingdom interactions for the development of small molecule inhibitors of Candida albicans biofilm formation’, Antimicrobial Agents and Chemotherapy, 60(10), pp. 5894-5905. doi: 10.1128/AAC.00190-16 | en |
dc.identifier.doi | 10.1128/AAC.00190-16 | en |
dc.identifier.endpage | 5905 | en |
dc.identifier.issn | 0066-4804 | |
dc.identifier.journaltitle | Antimicrobial Agents and Chemotherapy | en |
dc.identifier.startpage | 5894 | en |
dc.identifier.uri | https://hdl.handle.net/10468/8847 | |
dc.identifier.volume | 60 | en |
dc.language.iso | en | en |
dc.publisher | American Society for Microbiology | en |
dc.relation.project | info:eu-repo/grantAgreement/SFI/SFI Research Centres/12/RC/2275/IE/Synthesis and Solid State Pharmaceutical Centre (SSPC)/ | en |
dc.relation.project | info:eu-repo/grantAgreement/SFI/SFI Technology and Innovation Development Award (TIDA)/13/TIDA/B2625/IE/Small molecule inhibitors of HIF-1: a new class of anti-cancer therapeutics./ | en |
dc.relation.project | info:eu-repo/grantAgreement/SFI/SFI Technology and Innovation Development Award (TIDA)/12/TIDA/B2411/IE/Development of small molecule therapeutics for medical intervention: anti-biofilm inhibitors for the medical device sector./ | en |
dc.relation.project | info:eu-repo/grantAgreement/SFI/SFI Technology and Innovation Development Award (TIDA)/12/TIDA/B2405/IE/Optimised detection of key biomarkers of Pseudomonas aeruginosa towards a clinical application/ | en |
dc.relation.project | info:eu-repo/grantAgreement/SFI/SFI Technology and Innovation Development Award (TIDA)/14/TIDA/2438/IE/Next Generation Antibiotics: anti-biofilm, anti-pathogenic natural bioactives from marine microorganisms./ | en |
dc.relation.project | info:eu-repo/grantAgreement/EC/FP7::SP3::PEOPLE/607786/EU/BluePharmTrain/BLUEPHARMTRAIN | en |
dc.relation.project | info:eu-repo/grantAgreement/EC/FP7::SP1::KBBE/312184/EU/Increasing Value and Flow in the Marine Biodiscovery Pipeline/PHARMASEA | en |
dc.relation.project | info:eu-repo/grantAgreement/EC/FP7::SP1::KBBE/311975/EU/Marine Microorganisms: Cultivation Methods for Improving their Biotechnological Applications/MACUMBA | en |
dc.relation.project | info:eu-repo/grantAgreement/EC/FP7::SP1::KBBE/287589/EU/Marine Microbial Biodiversity, Bioinformatics and Biotechnology/MICRO B3 | en |
dc.relation.project | info:eu-repo/grantAgreement/EC/FP7::SP3::PEOPLE/256596/EU/Dissecting the role of a novel transcriptional regulator in microbial-host interactomes./MEXT REGULATION | en |
dc.relation.project | info:eu-repo/grantAgreement/EC/H2020::IA/634486/EU/Industrial Applications of Marine Enzymes: Innovative screening and expression platforms to discover and use the functional protein diversity from the sea/INMARE | en |
dc.relation.uri | https://aac.asm.org/content/60/10/5894 | |
dc.rights | © 2016, American Society for Microbiology. All Rights Reserved | en |
dc.subject | 4-Quinolones | en |
dc.subject | Antifungal agents | en |
dc.subject | Biofilms | en |
dc.subject | Candida albicans | en |
dc.subject | Cell Line | en |
dc.subject | Fungal proteins | en |
dc.subject | Gene expression regulation, fungal | en |
dc.subject | Humans | en |
dc.subject | Membrane glycoproteins | en |
dc.subject | Pseudomonas aeruginosa | en |
dc.subject | Quinolones | en |
dc.subject | Small molecule libraries | en |
dc.title | Exploiting interkingdom interactions for development of small-molecule inhibitors of Candida albicans biofilm formation | en |
dc.type | Article (peer-reviewed) | en |